Time is brain: Call for quicker MS diagnoses in Australia
A new report underscores the critical need for faster multiple sclerosis (MS) diagnoses in Australia. Released on World MS Day by MS Australia, the...
FLiRT variants sneak in as winter approaches
As Australia heads into winter, a new wave of COVID-causing sub-variants, dubbed FLiRT, has emerged. These variants, known as KP.1 and KP.2, are proving...
Tiny scans, big impact: Baby brain checks could slash future stroke risk
Researchers at the University of South Australia have uncovered a game-changing approach to reducing the risk of strokes later in life through early detection...
Gut feeling: How bacteria could be key to tackling Alzheimer’s
The old saying "you are what you eat" holds more truth than ever, especially with new research linking diet to brain health. Australian scientists...
Victoria faces triple threat: Flu, COVID, & RSV surge strains hospitals
Victoria is grappling with an infectious "soup" of influenza, COVID-19, and respiratory syncytial virus (RSV), resulting in increased hospitalisations and sick days across the...
Free financial counselling for those with mortgage, rental stress
The government today announced an extra $15 million to support key financial counselling services for people who are experiencing financial hardship due to mortgage...
Opinion: The complexity and power of shame
Shame is a potent emotion, capable of both burning and isolating individuals. It can leave them feeling cast aside and alone, with the potential...
A call to focus: MS Australia advocates for enhanced neurological research funding
The Australian Government's recent commitment to enhance health and medical research has been met with both applause and appeals for a sharper focus on...
New scholarships aim to amplify diversity in Australian STEM fields
Australia's commitment to diversifying its science, technology, engineering, and mathematics (STEM) workforce takes a solid step forward with the third installment of the Elevate...
AstraZeneca’s Vaxzevria bows out amid legal tussles
AstraZeneca's announcement of the worldwide discontinuation of its COVID-19 vaccine, Vaxzevria, marks a significant turning point in the pharmaceutical industry's response to the pandemic....